Signal active
Investment Firm
Overview
Level.VC invests in disruptive startups in Silicon Valley, NYC, and Israel that are directly developing machine learning, robot learning, and computer vision-powered solutions or are developing products & services powered by these technologies.
Highlights
2014
Venture Capital
1-10
4
0
1
Early Stage Venture, Seed
Venture Capital
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Level Ventures, established in 2014 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Seed investments across Financial Services, FinTech, Impact Investing, Wealth Management, Venture Capital, Finance, Asset Management, Angel Investment, Real Estate, Advice. The organization boasts a portfolio of 4 investments, with an average round size of $24.3M and 1 successful exits. Their recent investments include Artivest, Cota Capital, Anthemis, Founders Fund, RRE Ventures. The highest investment round they participated in was $18.1B. Among their most notable exits are Artivest and Cota Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
4
0
0
1
Investments
4
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
May 04, 2015 | Artivest | Financial Services | 15.0M |
Jul 10, 2017 | - | - | 3.0M |
Dec 21, 2022 | Enveda Biosciences | Biotechnology | 55.0M |
Jun 14, 2024 | Enveda Biosciences | Biotechnology | 55.0M |
Exits
1
Funding Timeline
4
0
0
Funding Rounds
4
Level Ventures has raised 4 rounds. Their latest funding was raised on Jun 14, 2024 from a Series B - Enveda Biosciences round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
May 04, 2015 | Series A - Artivest | - | 15.0M | - |
Jul 10, 2017 | Seed Round - Perceptive Automata | - | 3.0M | - |
Dec 21, 2022 | Series B - Enveda Biosciences | - | 55.0M | - |
Jun 14, 2024 | Series B - Enveda Biosciences | - | 55.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.